AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Janupil-M 50/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Psychotropics India Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Janupil-M 50/500mg Tablet

This dual-action tablet, containing 50mg/500mg of a carefully balanced medication combination, effectively manages elevated blood glucose in individuals diagnosed with type 2 diabetes. This dual approach helps mitigate serious diabetic complications, including renal impairment and vision loss, while potentially lowering the risk of cardiovascular events. The prescribed dosage, which may be standalone or supplemental to other diabetic therapies, is personalized based on individual health status, blood glucose readings, and concurrent medications. Consistent daily intake at the same time, coupled with meals, minimizes gastrointestinal discomfort. Adherence to the prescribed regimen, including diet and exercise as recommended by your physician, is crucial for optimal outcomes. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Concurrent use with insulin or sulfonylureas may increase the risk of hypoglycemia; understanding its symptoms and management is essential. Prior consultation with your physician is vital, particularly if you have a history of hepatic, renal, or cardiac conditions, pancreatic issues, or significant alcohol consumption. Similarly, pregnant or lactating individuals should seek medical advice before commencing treatment. Inform your doctor about all other medications you are taking to prevent potential interactions. Alcohol consumption should be minimized due to its hypoglycemic effects. Regular monitoring of kidney function and glucose levels will be conducted throughout treatment.

Primary Ingredients of Janupil-M 50/500mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Janupil-M 50/500mg Tablet

Managing type 2 diabetes

Major Benefits of Janupil-M 50/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Janupil-M 50/500mg tablet with a meal.

Common Side effects of Janupil-M 50/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Janupil-M 50/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Janupil-M 50/500mg Tablet should be administered with a meal.

How Janupil-M 50/500mg Tablet works:

Janupil-M 50/500mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Janupil-M 50/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Janupil-M 50/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against the risks before recommending its use. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Janupil-M 50/500mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Janupil-M 50/500mg tablets, as dose modification may be necessary. Consultation with a physician is recommended. For individuals with severe kidney disease, Janupil-M 50/500mg tablets are contraindicated. Routine monitoring of kidney function is advised during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from taking Janupil-M 50/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Janupil-M 50/500mg Tablet :

Should you forget a Janupil-M 50/500mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Janupil-M 50/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Janupil-M 50/500mg Tablet

Janupil-M 50/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Janupil-M 50/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Janupil-M 50/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Janupil-M 50/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Janupil-M 50/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Janupil-M 50/500mg Tablets. This occurs due to excessive lactic acid buildup in the blood. Because it's rare, metformin is avoided in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Janupil-M 50/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Janupil-M 50/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Janupil-M 50/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Janupil-M 50/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Janupil-M 50/500mg Tablets. This is due to a buildup of lactic acid in the blood and is rare, but avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Janupil-M 50/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Janupil-M 50/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Janupil-M 50/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Janupil-M 50/500mg Tablets are contraindicated in patients with allergies to any component or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Janupil-M 50/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Janupil-M 50/500mg Tablets. This is due to a buildup of lactic acid in the blood and is rare, but avoided in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience any of these, discontinue Janupil-M and seek immediate medical attention.
Prolonged use of Janupil-M 50/500mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Janupil-M 50/500mg Tablet
259